HDA issues statement on FDA’s phased exemption for eligible trading partners from the DSCSA’s final implementation requirements
“HDA and our pharmaceutical distributor members applaud the FDA’s decision to grant an exemption for the DSCSA’s enhanced drug distribution security (EDDS) requirements for eligible trading partners."